Table 2 Distribution of MDR, MHT-positive and blaNDM-2 and blaOXA-48 genes-harboring K. pneumoniae
K. pneumoniae count (N) | Carbapenem resistant | MHT positive | p-value | blaOXA-48 | blaNDM-2 |
|---|---|---|---|---|---|
(%)* | (%)* | (%)** | (%)** | ||
Sex | |||||
 Male (n = 37) | 26 (70.3%) | 23 (62.2%) | 0.07 | 4 (17.4%) | 6 (26.1%) |
 Female (n = 51) | 32 (62.7%) | 22 (43.1%) | 3 (13.6%) | 5 (22.7%) | |
Clinical samples | |||||
 Urine (n = 24) | 13 (54.1%) | 12 (50%) | 0.367 | 2 (16.7%) | 5 (41.7%) |
 Sputum (n = 23) | 18 (78.2%) | 10 (43.5%) | 1 (10%) | 2 (20.0%) | |
 Catheter tips (n = 14) | 9 (64.3%) | 7 (50.0%) | 1 (14.3%) | 1 (14.3%) | |
 Tracheal aspirates (n = 21) | 16 (76.2%) | 15 (71.4%) | 2 (13.3%) | 3 (20.0%) | |
 Others (n = 6) | 2 (33.3%) | 1 (16.7%) | 0 (0.0%) | 0 (0.0%) | |
Hospital units | |||||
 OPD (n = 41) | 24 (65.9%) | 19 (46.3%) | 0.627 | 3 (15.8%) | 3 (15.8%) |
 General ward (n = 27) | 16 (59.3%) | 13 (48.1%) | 1 (7.7%) | 2 (15.4%) | |
 ICU (n = 20) | 18 (90.0%) | 13 (65.1%) | 3 (23.1%) | 6 (46.2%) | |
Total | 58 (65.9%) | 45 (51.1%) | Â | 7 (15.6%) | 11 (24.4%) |